|
LYRA Lyra Therapeutics Inc 1327273 |
| Balance Sheet |
|
Current Assets
|
54,444,000 |
|
Assets
|
78,756,000 |
|
Current Liabilities
|
14,954,000 |
|
Liabilities
|
58,137,000 |
|
Equity
|
20,619,000 |
|
Shares Out
|
65,457,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-58,659,000 |
|
Investing Cash Flow
|
52,174,000 |
| Market Analysis |
Market Cap
|
18,157,701 |
|
Price
|
0.19 |
|
BVPS
|
0.32 |
|
PB
|
0.60 |
|
EPS
|
-1.61 |
|
PS
|
23.28 |
|
FCF
|
-6,485,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LYRA documents filed with the SEC.
LYRA Filings
Clear
